Cite
HARVARD Citation
Saxena, A. et al. (n.d.). Can PDL-1 levels predict response to triple regimen (carboplatin + pembrolizumab+ pemetrexed) in treatment for metastatic non-small cell lung cancer – a real world outcome study. Lung cancer. pp. S37-S38. [Online].